268 related articles for article (PubMed ID: 21289244)
41. Alternative genetic pathways in parathyroid tumorigenesis.
Farnebo F; Kytölä S; Teh BT; Dwight T; Wong FK; Höög A; Elvius M; Wassif WS; Thompson NW; Farnebo LO; Sandelin K; Larsson C
J Clin Endocrinol Metab; 1999 Oct; 84(10):3775-80. PubMed ID: 10523029
[TBL] [Abstract][Full Text] [Related]
42. p27 variant and corticotropinoma susceptibility: a genetic and in vitro study.
Sekiya T; Bronstein MD; Benfini K; Longuini VC; Jallad RS; Machado MC; Goncalves TD; Osaki LH; Higashi L; Viana J; Kater C; Lee M; Molatore S; Francisco G; Chammas R; Naslavsky MS; Schlesinger D; Gama P; Duarte YA; Lebrão ML; Zatz M; Meirelles O; Liberman B; Fragoso MC; Toledo SP; Pellegata NS; Toledo RA
Endocr Relat Cancer; 2014 Jun; 21(3):395-404. PubMed ID: 24532476
[TBL] [Abstract][Full Text] [Related]
43. ARMC5 Alterations in Patients With Sporadic Neuroendocrine Tumors and Multiple Endocrine Neoplasia Type 1 (MEN1).
Damjanovic SS; Antic JA; Elezovic-Kovacevic VI; Dundjerovic DM; Milicevic IT; Beleslin-Cokic BB; Ilic BB; Rodic GS; Berthon A; Maria AG; Faucz FR; Stratakis CA
J Clin Endocrinol Metab; 2020 Dec; 105(12):e4531-42. PubMed ID: 32901291
[TBL] [Abstract][Full Text] [Related]
44. Genetic analyses in patients with familial isolated hyperparathyroidism and hyperparathyroidism-jaw tumour syndrome.
Mizusawa N; Uchino S; Iwata T; Tsuyuguchi M; Suzuki Y; Mizukoshi T; Yamashita Y; Sakurai A; Suzuki S; Beniko M; Tahara H; Fujisawa M; Kamata N; Fujisawa K; Yashiro T; Nagao D; Golam HM; Sano T; Noguchi S; Yoshimoto K
Clin Endocrinol (Oxf); 2006 Jul; 65(1):9-16. PubMed ID: 16817812
[TBL] [Abstract][Full Text] [Related]
45. Case Report: New CDKN1B Mutation in Multiple Endocrine Neoplasia Type 4 and Brief Literature Review on Clinical Management.
Lavezzi E; Brunetti A; Smiroldo V; Nappo G; Pedicini V; Vitali E; Trivellin G; Mazziotti G; Lania A
Front Endocrinol (Lausanne); 2022; 13():773143. PubMed ID: 35355569
[TBL] [Abstract][Full Text] [Related]
46. Novel somatic MEN1 gene alterations in sporadic primary hyperparathyroidism and correlation with clinical characteristics.
Scarpelli D; D'Aloiso L; Arturi F; Scillitani A; Presta I; Bisceglia M; Cristofaro C; Russo D; Filetti S
J Endocrinol Invest; 2004 Dec; 27(11):1015-21. PubMed ID: 15754732
[TBL] [Abstract][Full Text] [Related]
47. Frequency of somatic MEN1 gene mutations in monoclonal parathyroid tumours of patients with primary hyperparathyroidism.
Miedlich S; Krohn K; Lamesch P; Müller A; Paschke R
Eur J Endocrinol; 2000 Jul; 143(1):47-54. PubMed ID: 10870030
[TBL] [Abstract][Full Text] [Related]
48. MEN-4 and other multiple endocrine neoplasias due to cyclin-dependent kinase inhibitors (p27(Kip1) and p18(INK4C)) mutations.
Georgitsi M
Best Pract Res Clin Endocrinol Metab; 2010 Jun; 24(3):425-37. PubMed ID: 20833334
[TBL] [Abstract][Full Text] [Related]
49. Somatic mutations of multiple endocrine neoplasia type 1 gene in the sporadic endocrine tumors.
Shan L; Nakamura Y; Nakamura M; Yokoi T; Tsujimoto M; Arima R; Kameya T; Kakudo K
Lab Invest; 1998 Apr; 78(4):471-5. PubMed ID: 9564891
[TBL] [Abstract][Full Text] [Related]
50. Clinical Features of Multiple Endocrine Neoplasia Type 4: Novel Pathogenic Variant and Review of Published Cases.
Frederiksen A; Rossing M; Hermann P; Ejersted C; Thakker RV; Frost M
J Clin Endocrinol Metab; 2019 Sep; 104(9):3637-3646. PubMed ID: 30990521
[TBL] [Abstract][Full Text] [Related]
51. Mutational analysis of Smad3, a candidate tumor suppressor implicated in TGF-beta and menin pathways, in parathyroid adenomas and enteropancreatic endocrine tumors.
Shattuck TM; Costa J; Bernstein M; Jensen RT; Chung DC; Arnold A
J Clin Endocrinol Metab; 2002 Aug; 87(8):3911-4. PubMed ID: 12161532
[TBL] [Abstract][Full Text] [Related]
52. Somatic and germline mutations in the pathogenesis of pituitary adenomas.
Vandeva S; Daly AF; Petrossians P; Zacharieva S; Beckers A
Eur J Endocrinol; 2019 Dec; 181(6):R235-R254. PubMed ID: 31658440
[TBL] [Abstract][Full Text] [Related]
53. Do Patients With Atypical Parathyroid Adenoma Need Close Follow-up?
Saponaro F; Pardi E; Mazoni L; Borsari S; Torregrossa L; Apicella M; Frustaci G; Materazzi G; Miccoli P; Basolo F; Marcocci C; Cetani F
J Clin Endocrinol Metab; 2021 Oct; 106(11):e4565-e4579. PubMed ID: 34157106
[TBL] [Abstract][Full Text] [Related]
54. Functional characterization of a CDKN1B mutation in a Sardinian kindred with multiple endocrine neoplasia type 4 (MEN4).
Pardi E; Mariotti S; Pellegata NS; Benfini K; Borsari S; Saponaro F; Torregrossa L; Cappai A; Satta C; Mastinu M; Marcocci C; Cetani F
Endocr Connect; 2015 Mar; 4(1):1-8. PubMed ID: 25416039
[TBL] [Abstract][Full Text] [Related]
55. Absence of somatic RET gene mutation in sporadic parathyroid tumors and hyperplasia secondary to uremia, and absence of somatic Men1 gene mutation in MEN2A-associated hyperplasia.
Uchino S; Noguchi S; Nagatomo M; Sato M; Yamashita H; Yamashita H; Watanabe S; Murakami T; Toda M; Wakiya S; Adachi M
Biomed Pharmacother; 2000 Jun; 54 Suppl 1():100s-103s. PubMed ID: 10915003
[TBL] [Abstract][Full Text] [Related]
56. Primary Hyperparathyroidism Focused on Molecular Pathogenesis.
Gómez Sáez JM
Eur Endocrinol; 2014 Aug; 10(2):153-156. PubMed ID: 29872481
[TBL] [Abstract][Full Text] [Related]
57. MEN1 gene alterations do not correlate with the phenotype of sporadic primary hyperparathyroidism.
Cetani F; Pardi E; Vignali E; Borsari S; Picone A; Cianferotti L; Ambrogini E; Miccoli P; Pinchera A; Marcocci C
J Endocrinol Invest; 2002 Jun; 25(6):508-12. PubMed ID: 12109621
[TBL] [Abstract][Full Text] [Related]
58. Differential loss of heterozygosity in familial, sporadic, and uremic hyperparathyroidism.
Farnebo F; Teh BT; Dotzenrath C; Wassif WS; Svensson A; White I; Betz R; Goretzki P; Sandelin K; Farnebo LO; Larsson C
Hum Genet; 1997 Mar; 99(3):342-9. PubMed ID: 9050920
[TBL] [Abstract][Full Text] [Related]
59. Mutational analysis of the vitamin D receptor does not support its candidacy as a tumor suppressor gene in parathyroid adenomas.
Samander EH; Arnold A
J Clin Endocrinol Metab; 2006 Dec; 91(12):5019-21. PubMed ID: 17003089
[TBL] [Abstract][Full Text] [Related]
60. MENX.
Pellegata NS
Ann Endocrinol (Paris); 2012 Apr; 73(2):65-70. PubMed ID: 22542001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]